Decreased Ubiquinone Availability and Impaired Mitochondrial Cytochrome Oxidase Activity Associated With Statin Treatment

REFERENCES

• A. Almeida, S. Moncada, and J. P. Bolanos. (2004). Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat. Cell Biol. 6:45–51.
   PubMed Web of Science ®Google Scholar
• J. Arenas, M. A. Fernandez-Moreno, J. A. Molina, and et al (2003). Myoglobinuria and COX deficiency in a patient taking cerivastatin and gemfibrozil. Neurology 60:124–132.
   PubMed Web of Science ®Google Scholar
• M. Arnadottir, L.-O. Eriksson, H. Thysell, and J. D. Karkas. (1993). Plasma concentration profiles of simvastatin 3-hydroxy-3-methyl-glutaryl-coemzyme A reductase inhibitory activity in kidney transplant recipients with and without ciclosporin. Nephron 65:410–413.
   PubMed Web of Science ®Google Scholar
• J. P. Bolanos, S. J. Heales, and J. B. Clark. (1995). Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64:1965–1972.
   PubMed Web of Science ®Google Scholar
• E. Bruckert. (2002). New advances in lipid-modifying therapies for reducing cardiovascular risk. Cardiology 97:59–66.
   PubMed Web of Science ®Google Scholar
• A. A. Carvalho, U. W. P. Lima, and R. A. Valiente. (2004). Statin and fibrate associated myopathy. Arq. Neuropsiquiatr. 62:257–261.
   PubMed Web of Science ®Google Scholar
• F. Diaz, C. K. Thomas, S. Garcia, and et al (2005). Mice lacking COX10 in skeletal muscle recapitulate the phenotype of progressive mitochondrial myopathies associated with cytochrome c oxidase deficiency. Hum. Mol. Genet. 14:2737–2748.
   PubMed Web of Science ®Google Scholar
• J. Dimitroulakos, and H. Yeger. (1996). HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells. Nat. Med. 2:326–333.
   PubMed Web of Science ®Google Scholar
• A. J. Duncan, S. J. R. Heales, K. Mills, and et al (2005). Determination of Coenzyme Q10 in blood mononuclear cells, skeletal muscle and plasma by HPLC using di-propoxy-Coenzyme Q10 as an internal standard. Clin. Chem. 51:2380–2382.
   PubMed Web of Science ®Google Scholar
• A. Endo, M. Kuroda, and K. Tanzawa. (1976). Competittive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett. 72:323–326.
   PubMed Web of Science ®Google Scholar
• J. Ericsson, and G. Dallner. (1993). Distribution, biosynthesis, and function of mevalonate pathway lipids. Subcell. Biochem. 21:229–272.
   PubMedGoogle Scholar
• L. Ernster, and G. Dallner. (1995). Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1271:195–204.
   PubMed Web of Science ®Google Scholar
• L. Ernster, and P. Forsmark-Andree. (1993). Ubiquinol: an endogenous antioxidant in aerobic organisms. Clin. Invest. 40:380–390.
   Google Scholar
• E. Estornell, R. Fato, C. Castelluccio, and et al (1992). Saturation kinetics of coenzyme Q in NADH and succinate oxidation in beef heart mitochondria. FEBS Lett. 311:107–109.
   PubMed Web of Science ®Google Scholar
• J. A. Farmer, and G. Torre-Amione. (2000). Comparative tolerability of the HMG-CoA reductase inhibitors. Drug Saf. 23:197–213.
   PubMed Web of Science ®Google Scholar
• J. R. Faust, M. S. Brown, and J. L. Goldstein. (1980). Synthesis of delta 2-isopentenyl tRNA from mevalonate in cultured human fibroblasts. 255:6546–6548.
   Google Scholar
• K. Folkers, P. Langsjoen, R. Willis, and et al (1990). Lovastatin decreases coenzyme Q levels in humans. Proc. Natl. Acad. Sci. USA 87:8931–8934.
   PubMed Web of Science ®Google Scholar
• M. E. Gegg, B. Beltran, S. Salas-Pino, and et al (2003). Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration?. J. Neurochem. 86:228–237.
   PubMed Web of Science ®Google Scholar
• I. Hamilton-Craig. (2001). Statin-associated myopathy. Med. J. Aust. 175:486–489.
   PubMed Web of Science ®Google Scholar
• I. P. Hargreaves, A. J. Duncan, S. J. R. Heales, and et al (2005). The effect of HMG-CoA reductase inhibitors on Coenzyme Q10. Drug Saf. 28:659–676.
   PubMed Web of Science ®Google Scholar
• S. J. R. Heales, J. P. Bolanos, M. P. Brand, and et al (1996a). Mitochondrial damage: an important feature in a number of inborn errors of metabolism. J. Inher. Metab. Dis. 19:140–142.
   PubMed Web of Science ®Google Scholar
• S. J. R. Heales, I. P. Hargreaves, S. E. Olpin, and et al (1996b). Diagnosis of mitochondrial electron transport chain defects in small muscle biopsies. J. Inher. Metab. Dis. 19 (Suppl 1):151.
   Google Scholar
• C. W. Holtzman, B. S. Wiggins, and S. A. Spinler. (2006). Role of P-glycoprotein in statin drug interactions. Pharmacotherapy 26:1601–1607.
   PubMed Web of Science ®Google Scholar
• K. C. Huang, C. W. Chen, J. C. Chen, and et al (2003). HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages. J. Biomed. Sci. 10:396–405.
   PubMed Web of Science ®Google Scholar
• U. Ikeda, M. Shimpo, M. Ikeda, and et al (2001). Lipophilic statins augment inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. J. Cardiovasc. Pharm. 38:69–77.
   PubMed Web of Science ®Google Scholar
• J. Jacobson, M. Duchen, J. Hothersall, and et al (2005). Induction of mitochondrial oxidative stress in astrocytes by nitric oxide precedes disruption of energy metabolism. J. Neurochem. 95:388–395.
   PubMed Web of Science ®Google Scholar
• J. M. Keenan. (2003). Treatment of patients with lipid disorders in the primary care setting: new guidelines and their implications. South Med. J. 96:266–275.
   PubMed Web of Science ®Google Scholar
• G. Keilhoff, and G. Wolf. (1993). Comparison of double fluorescence staining and LDH-test for monitoring cell viability in vitro. Neuroreport 18:125–132.
   Google Scholar
• T. S. King. (1967). Preparations of succinate-cytochrome c reductase and the cytochrome b-c1 particle, and reconstitution of succinate-cytochrome c reductase. Methods Enzymol. 10:217–235.
   Google Scholar
• R. Laaksonen, J.-P. Ojala, M. J. Tikkanen, and et al (1994). Serum ubiquinone concentrations after short and long-term treatment with HMG-CoA reductase inhibitors. Eur. Clin. Pharmacol. 46:313–317.
   Web of Science ®Google Scholar
• U. Laufts, V. La Fata, J. Plutzky, and et al (1998). Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129–1135.
   PubMed Web of Science ®Google Scholar
• C. A. Lemmi, P. C. Pelikan, B. Geesaman, and et al (1990). Kinetics of cyclosporine A-induced inhibition of succinate-coenzyme Q dehydrogenase in rat renal cortical mitochondria. Biochem. Med. Metab. Biol. 43:214–225.
   PubMedGoogle Scholar
• N. N. Malik. (2004). Over the counter statins. Lancet 364:411.
   PubMedGoogle Scholar
• W. A. Maltese, and J. R. Aprille. (1985). Relation of mevalonate synthesis to mitochondrial ubiquinone content and respiratory function in cultured neuroblastoma cells. J. Biol. Chem. 260:11524–11529.
   PubMed Web of Science ®Google Scholar
• J. M. McKenney. (2003). Pharmacologic characteristics of statins. Clin. Cardiol. 26 (Suppl 3):III32–III38.
   PubMedGoogle Scholar
• A. J. Mortensen, A. Leth, E. Agner, and et al (1997). Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Mol. Aspects Med. 18S:137–144.
   Google Scholar
• R. Neale, T. M. Reynolds, and W. Saweirs. (2004). Statin precipitated lactic acidosis. J. Clin. Pathol. 57:989–990.
   PubMed Web of Science ®Google Scholar
• P. J. Neuvonen, T. Kantola, and K. T. Kivisto. (1998). Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole. Clin. Pharmacol. Ther. 63:332–341.
   PubMed Web of Science ®Google Scholar
• S. Ogasahara, A. Engel, D. Frens, and et al (1989). Muscle coenzyme Q deficiency in familial mitochondrial encephalomyositis. Proc. Natl. Acad. Sci. USA 86:2379–2382.
   PubMed Web of Science ®Google Scholar
• K. Pahan, F. G. Sheikh, A. M. S. Namboodiri, and et al (1997). Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia and macrophages. J. Clin. Invest. 100:2971–2979.
   Web of Science ®Google Scholar
• H. Päivä, K. M. Thelen, R. Van Coster, and et al (2005). High dose statins and skeletal muscle metabolism in humans: a randomized controlled trial. Clin. Pharm. Ther 78:60–68.
   PubMed Web of Science ®Google Scholar
• P. S. Philips, R. H. Haas, S. Bannykh, and et al (2002). Statin-associated myopathy with normal creatine kinase levels. Ann. Intern. Med. 137:581–585.
   PubMed Web of Science ®Google Scholar
• C. I. Ragan, M. T. Wilson, V. M. Darley-Usmar, et al (1987). Subfractionation of mitochondria and isolation of the proteins of oxidative phosphorylation. In V. M. Darley-Usmar, D. Rickwood, and M. T. Wilson. (Eds.), Mitochondria, a practical approach, IRL Press, London, pp. 79–112.
   Google Scholar
• S. Rahman, I. Hargreaves, P. Clayton, and et al (2001). Neonatal presentation of coenzyme Q10 deficiency. J. Pediatrics 139:456–458.
   PubMed Web of Science ®Google Scholar
• R. Rattan, S. Giri, A. K. Singh, and et al (2003). Rho A negatively regulates cytokine-mediated inducible nitric oxide synthase expression in brain-derived transformed cell lines: negetive regulation of IKKα. Free Radic. Biol. Med. 9:1037–1050.
   Google Scholar
• B. A. Schick, R. Laaksonen, J. J. Frohlich, H. Paiva, T. Lehtimaki, K. H. Humphries, and et al (2007). Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin. Clin. Pharmacol. Ther. 81:650–653.
   PubMed Web of Science ®Google Scholar
• G. Schmitz, and W. Drobnik. (2003). Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy. Clin. Chem. Lab. Med. 41:581–589.
   PubMed Web of Science ®Google Scholar
• M. A. Selak, J. P. de Chadarevian, and J. J. Melvin. (2000). Mitochondrial activity in Pompe's disease. Pediatr. Neurol. 23:54–57.
   PubMed Web of Science ®Google Scholar
• J. A. Shepherd, and P. B. Garland. (1969). The kinetic properties of citrate synthase from rat liver mitochondria. Biochem. J. 114:597–610.
   PubMed Web of Science ®Google Scholar
• V. C. Stewart, J. M. Land, J. B. Clark, and S. J. Heales. (1998). Comparison of mitochondrial respiratory chain enzyme activities in rodent astrocytes and neurones and a human astrocytoma cell line. Neurosci. Lett. 247:201–203.
   PubMed Web of Science ®Google Scholar
• V. C. Stewart, M. A. Sharp, J. B. Clark, and et al (2000). Astrocyte-derived nitric oxide causes both reversible and irreversible damage to the neuronal mitochondrial respiratory chain. J. Neurochem. 75:694–700.
   PubMed Web of Science ®Google Scholar
• A. Tabernero, J. P. Bolaños, and J. M. Medina. (1993). Lipogenesis from lactate in rat neurons and astrocytes in primary culture. Biochem. J. 294:635–638.
   PubMed Web of Science ®Google Scholar
• S. Tavintharan, C. N. Ong, K. Jeyaseelan, M. Sivakumar, S. C. Lim, and C. F. Sum. (2007). Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high dose simvastatin: A possible role in statin-induced hepatotoxicity?. Toxicol. Appl. Pharmacol. 223:173–179.
   PubMed Web of Science ®Google Scholar
• P. D. Thompson, P. Clarkson, and R. H. Karas. (2003). Statin-associated myopathy. JAMA 289:1681–1690.
   PubMed Web of Science ®Google Scholar
• A. Vassault. (1983). L-Lactate dehydrogenase. UV method with pyruvate and NADH. In J. Bergmeyer, and M. Grassl. (Eds.), Methods of Enzymic Analysis, Vol 3, Verlag Chemie GmbH, Weinheim, pp. 118–126.
   Google Scholar
• B. K. Wagner, T. Kitami, T. J. Gilbert, D. Peck, A. Ramanathan, S. L. Screiber, and et al (2008). Large-scale chemical dissection of mitochondrial function. Nat. Biotechnol. 26:343–351.
   PubMed Web of Science ®Google Scholar
• W. Weber. (2001). Drug firm withdraws statins from the market. Lancet 358:568.
   PubMed Web of Science ®Google Scholar
• D. C. Wharton, and A. Tzagoloff. (1967). Cytochrome oxidase from beef heart mitochondria. Methods Enzymol. 10:245–250.
   Google Scholar
• R. A. Willis, K. Folkers, J. L. Tucker, and et al (1990). Lovastatin decreases coenzyme Q levels in rats. Proc. Natl. Acad. Sci. USA 87:8928–8930.
   PubMed Web of Science ®Google Scholar